Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancerXinyuan Tong, Hongbin Ji, Khrystyna Myndzar et al.|Cancer Cell|2024Cited by 115
A neomorphic protein interface catalyzes covalent inhibition of RAS <sup>G12D</sup> aspartic acid in tumorsCaroline E. Weller, David Wildes, G. Leslie Burnett et al.|Science|2025Cited by 31
Mutant KRAS regulates transposable element RNA and innate immunity via KRAB zinc-finger genesRoman E. Reggiardo, Daniel H. Kim, Sreelakshmi Velandi Maroli et al.|Cell Reports|2022Cited by 17
Comprehensive structure-function analysis reveals gain- and loss-of-function mechanisms impacting oncogenic KRAS activityJason J. Kwon, Andrew J. Aguirre, Julien Dilly et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 9
Epigenomic reprogramming of repetitive noncoding RNAs and IFN-stimulated genes by mutant KRASRoman E. Reggiardo, Daniel H. Kim, Sreelakshmi Velandi Maroli et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 7